214 related articles for article (PubMed ID: 16158963)
1. Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
Gruber BM; Anuszewska EL; Bubko I; Gozdzik A; Priebe W; Fokt I
Anticancer Res; 2005; 25(3B):2193-8. PubMed ID: 16158963
[TBL] [Abstract][Full Text] [Related]
2. Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
Gruber BM; Anuszewska EL; Bubko I; Goździk A; Fokt I; Priebe W
Arch Immunol Ther Exp (Warsz); 2007; 55(3):193-8. PubMed ID: 17557149
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
[TBL] [Abstract][Full Text] [Related]
5. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
6. NFkappaB activation and drug sensitivity in human neoplastic cells treated with anthracyclines.
Gruber BM; Anuszewska EL; Bubko I; Kasprzycka-Guttman T; Misiewicz I; Skupińska K; Fokt I; Piebe W
Acta Pol Pharm; 2008; 65(2):267-71. PubMed ID: 18666436
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells.
Gruber BM; Anuszewska EL; Roman I; Goździk A; Priebe W; Fokt I
Acta Pol Pharm; 2006; 63(1):15-8. PubMed ID: 17515324
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.
Swift LP; Rephaeli A; Nudelman A; Phillips DR; Cutts SM
Cancer Res; 2006 May; 66(9):4863-71. PubMed ID: 16651442
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II as the primary target of anti-tumor anthracyclines.
Zunino F; Capranico G
Anticancer Drug Des; 1990 Nov; 5(4):307-17. PubMed ID: 1963303
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
11. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
12. Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling.
Maestre N; Tritton TR; Laurent G; Jaffrézou JP
Cancer Res; 2001 Mar; 61(6):2558-61. PubMed ID: 11289131
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60/MX2 resistant cells.
Kik K; Wasowska-Lukawska M; Oszczapowicz I; Szmigiero L
Anticancer Res; 2009 Apr; 29(4):1429-33. PubMed ID: 19414398
[TBL] [Abstract][Full Text] [Related]
14. Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues.
Trevino AV; Woynarowska BA; Herman TS; Priebe W; Woynarowski JM
Mol Cancer Ther; 2004 Nov; 3(11):1403-10. PubMed ID: 15542779
[TBL] [Abstract][Full Text] [Related]
15. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines.
Gambi N; Tramontano F; Quesada P
Biochem Pharmacol; 2008 Jun; 75(12):2356-63. PubMed ID: 18468580
[TBL] [Abstract][Full Text] [Related]
17. Differential apoptotic response in HPV-infected cancer cells of the uterine cervix after doxorubicin treatment.
Suh DS; Kim SC; An WG; Lee CH; Choi KU; Song JM; Jung JS; Lee KS; Yoon MS
Oncol Rep; 2010 Mar; 23(3):751-6. PubMed ID: 20127016
[TBL] [Abstract][Full Text] [Related]
18. Possible role of HSP60 in synergistic action of anthracyclines and sulindac in HeLa cells.
Gruber BM; Krzysztoń-Russjan J; Bubko I; Anuszewska EL
Acta Pol Pharm; 2010; 67(6):620-4. PubMed ID: 21229877
[TBL] [Abstract][Full Text] [Related]
19. Can cytotoxic activity of anthracyclines be related to DNA damage?
Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H
Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255
[TBL] [Abstract][Full Text] [Related]
20. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
